ChemDmart
Chemxpert Database
  • About
    • About
    • Leadership
    • Advisory Board
  • Products
    • ChemProtel - Product Intelligence
    • CompFolio - One Company Profile
    • CompGroupe - Group Company Profile
    • ChemScape - Data Landscape
    • ChemDmart - E-Market Place
    • DataIntel - Data Analytics/Trends
    • DataFeed - Data News/Feed
    • CompShow- Company Showcase
  • Sources
  • Subscription
  • User Guide
  • Contact
  • Book Demo Log In
  1. Home
  2. All News
  3. Lemonexs Mrna Degradaball Vaccine Lem Mr203 Ind Application Approved For Phase 1 Clinical Trial
News Feed
course image
  • Date not available
  • Admin
  • News Article

Lemonexs mRNA-DegradaBALL Vaccine (LEM-mR203) IND Application Approved for Phase 1 Clinical Trial

Lemonex announced the approval of an Investigational New Drug (IND) application by the Ministry of Food and Drug Safety (MFDS) for revolutionary mRNA vaccine candidate, LEM-mR203, which incorporates their pioneering nano-drug delivery technology, DegradaBALL®.

The scope of this clinical trial encompasses the evaluation of safety and immunogenicity in healthy adults with a specific focus on addressing the ongoing Covid-19 pandemic. Distinguished by its unique attribute, LEM-mR203 is the first mRNA vaccine candidate to integrate the proprietary drug delivery platform technology, DegradaBALL-mRNA system. 

The current lipid nanoparticle (LNP) technology used in existing mRNA vaccines has problems related to allergic reactions or heart issues like myocarditis. The newly developed DegradaBALL drug delivery technology holds promise in mitigating these concerns, suggesting advancement for mRNA vaccines and therapeutics.

The mRNA vaccines offer an accelerated response due to their rapid development cycle compared to antigen protein vaccines. Nevertheless, the efficacy of mRNA delivery within the body hinges on proficient drug delivery technology.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!

Categories

image
Product Related Updates
image
Certificates/Accreditation
image
Approval/Launch
image
Clinical Trial Update
image
Licensing/Partnering/Collaboration Deal
image
ODD/BTA/FTA Status
image
Merger/Acquisition
image
Warning/Recalls

Lifescience Intellipedia Pvt. Ltd.

C-89, Sector-65 Noida-U.P. 201301 (India)
Toll-Free: 18004190155
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com

USEFUL LINKS

  • Home
  • Privacy Policy
  • Terms & Conditions
  • Terms Of Use
  • Refund Policy
  • Blogs

OUR PRODUCTS

  • ChemProtel - Product Intelligence
  • CompFolio - One Company Profile
  • CompGroupe - Group Company Profile
  • ChemScape - Data Landscape
  • ChemDmart - E-Market Place
  • DataIntel - Data Analytics/Trends
  • DataFeed - Data News/Feed
  • CompShow- Company Showcase

LOCATION

© Copyright Lifescience Intellipedia Pvt. Ltd.. All Rights Reserved

Fill The Form